New Data Focus Need for Tailored Schizophrenia Care in Elderly

Older adults with schizophrenia are not a homogenous patient population, with various subgroups that differ significantly in terms of comorbid illness and mortality rates and causes, new research shows. For example, individuals in a group characterized by substance use disorders (SUDs) had a depression prevalence of about 60% and relatively high death rates from unintentional … Read more

FDA, DEA Pushed to Make Gabapentin a Controlled Substance

In a bid to stop abuse and diversion of the anticonvulsant gabapentin, a watchdog group is petitioning federal regulators to make the drug a controlled substance. The nonprofit group Public Citizen has filed a petition with the US Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA), arguing that medication’s risks additional safeguards. … Read more